The new category of t(14;18)-negative CD23+ follicle center lymphoma (FCL), which can have a follicular as well as a diffuse growth pattern, has been proposed by the 2022 ICC as a provisional entity [2]. Here, FCER2 is linked to intrahepatic cholangiocarcinoma.